USA Today: How and why coronavirus makes you sick
UC expert explains the mechanics of how people develop COVID-19
USA Today turned to Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases as the lone medical source for a story explaining how the coronavirus spreads from person to person and physically impacts people who develop COVID-19.
Illustration from USA Today showing how the coronavirus infects people. Photo credit/Kevin Necessary/Cincinnati Enquirer
Dr. Fichtenbaum told USA Today the virus is spread when an infected person expels tiny droplets from the mouth, throat or lungs, usually during a cough or sneeze.
“Viruses need something else’s machinery to help generate them,” Fichtenbaum says. “They’re what we call a parasite.”
Fichtenbaum said the reason some people with COVID-19 lose their sense of smell is because the virus somehow interferes with the olfactory nerve, which transmits sensory data to the brain and is responsible for the sense of smell.
Read the article here.
Featured image at top Dr. Carl Fichtenbaum/Photo credit/Colleen Kelley/UC Creative Services + Brand
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.